IFNA1 and hepatitis C virus infection: In addition, liver biopsy studies showed that decreased miR-122 levels in individuals with hepatitis C are associated with a poor response to IFN therapy (Sarasin-Filipowicz et al., 2009; Urban et al., 2010), suggesting that abundant miR-122 in hepatocytes promotes cellular responses to IFN treatment.